Clinical Trial Update: Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema [Phase 4]

View source ↗

Summary

A Phase 4 single-arm trial evaluating the efficacy and safety of brolucizumab for persistent diabetic macular edema, with status listed as ACTIVE_NOT_RECRUITING…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Diabetic Macular Edema | Phase 4 | Status: ACTIVE_NOT_RECRUITING